Reduced alpha diversity of the oral microbiome correlates with short progression-free survival in patients with relapsed/refractory multiple myeloma treated with ixazomib-based therapy (AGMT MM 1, phase II trial)
口腔微生物群α多样性降低与接受伊沙佐米治疗的复发/难治性多发性骨髓瘤患者的无进展生存期缩短相关(AGMT MM 1,II期试验)
期刊:eJHaem
影响因子:1.2
doi:10.1002/jha2.130
Ludwig, Heinz; Hausmann, Bela; Schreder, Martin; Pönisch, Wolfram; Zojer, Niklas; Knop, Stefan; Gunsilius, Eberhard; Egle, Alexander; Petzer, Andreas; Einsele, Hermann; Hajek, Roman; Weisel, Katja; Krenosz, Karl Jochen; Lang, Alois; Lechner, Daniel; Greil, Richard; Berry, David